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ABSTRACT Using the simian virus 40 "enhancer trap" 
approach, we have identified a transcription enhancer located 
just upstream of the major immediate early gene of murine 
cytomegalovirus. This enhancer has several striking proper-
ties. (.) Together with the enhancer ofhuman cytomegalovirus, 
it is the strongest transcription enhancer found to date. (ö) It 
is an extremely long enhancer, spanning >700 base pairs. (ÜI) 
It consists of a rather complex pattern of sequence repeats, the 
longest of which is 181 base pairs. Also, several types of short 
sequence motifs are scattered throughout the enhancer in 
monomeric, heterodimeric, or homodimeric (palindromic) 
form. These motifs have been identified to be components of 
other enhancers and promoters, and they are presumably 
binding sites for specific nuclear factors. Our analysis suggests 
that enhancers are composed of a modular arrangement of 
short conserved sequence motifs and that enhancer strength is 
correlated with the redundancy of these motifs. 
Murine cytomegalovirus (MCMV) is a member of the highly 
diverse group of herpesviruses. Even among cytomegalovi-
ruses of different host species there can be wide variation. 
For example, MCMV differs considerably from the human 
cytomegalovirus (HCMV) with respect to biological proper-
ties, immediate early (JE) gene organization, and overall 
nucleotide sequence. The 235-kilobase-pair (kbp) genome of 
MCMV also lacks large internal and terminal repeats char-
acteristic of HCMV. Accordingly, no isomeric forms of the 
MCMV genome exist (1, 2). 
As in other members of the herpes group, MCMV gene 
expression is temporally regulated. JE genes are expressed in 
the absence ofprotein synthesis, early gene products depend 
on the synthesis of at least one JE gene product, and late 
RNAs are synthesized after the onset of viral DNA synthesis. 
MCMV has one major JE region (3, 4). This region codes 
for one major 2.75-kb and five minor polyadenylylated IE 
RNAs (unpublished data). Low levels of IE transcripts have 
also been detected from both termini ofthe genome (3, 4). In 
an attempt to answer the question of how transcription is 
regulated, we decided to look for a transcription enhancer 
that might control the IE promoter. 
Transcription enhancers are cis-acting DNA elements that 
are able to activate RNA polymerase II-transcribed genes in 
either orientation from a distance of up to several kbp from 
the promoter site (5, 6), even when located downstream ofthe 
transcribed sequences (ref. 5; for reviews, see refs. 7-9). 
Originally detected in papovaviruses, their presence has 
since been demonstrated in a number of animal viruses, 
including herpesviruses such as herpes simplex (10), HCMV 
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(11), and Herpesvirus saimiri (12). Some enhancers--e.g., 
the enhancers from simian virus 40 (SV40) and HCMV-can 
function in a number of different cell types, while others show 
a distinct host-cell preference. Enhancers that are associated 
with cellular genes--e.g., immunoglobulin genes (13-15), rat 
insulin (16), and a munne class 11 major histocompatibility 
antigen gene (17)-are often strictly cell-type specific. 
Tbe fact that in SV 40 the enhancer can be substituted by 
heterologous enhancers has led to the development of the 
SV40 "enhancer trap," whereby enhancerless SV40 DNA 
regains infectivity by incorporating an exogenous enhancer 
(18). The enhancer trap allows the selection of a transcription 
enhancer from a large excess of DNA. By cotransfecting 
enhancer trap DNA and the entire MCMV genome or DNA 
from its major JE region, we have been able to recover a very 
strong transcription enhancer upstream of the major JE 
region of MCMV. Tbe MCMV enhancer has been sequenced 
and its location with respect to the JE region has been 
determined. Sequence analysis revealed a complex arrange-
ment of repeats and also short DNA motifs found in other 
enhancers, which presumably are binding sites for nuclear 
proteins. 
MATERIALS AND METHODS 
Recombinant DNAs. Xba 1- and Kpn I-digested enhancer 
trap DNA (l/Lg) (clone pET-I; ref. 18) was mixed with 10 /Lg 
of sonicated MCMV -specific DNA and used for transfection 
of monkey kidney CV -1 cells by the calcium phosphate 
technique. Viral DNA was extracted from CV-l cells, cloned 
into the BamHI site of pBR327, and analyzed as described 
(18). Tbe molecular cloning of MCMV DNA has been 
described (1, 4). 
CeU and Virus Culture and Transfections. HeLa and CV-l 
cells were cultured as described (18). Propagation ofMCMV 
(strain Smith, ATCC VR-194) in BALB/c mouse embryo 
fibroblasts, purification of MCMV virus particles, viral 
DNA, and viral RNA have been described (1, 4). 
Transfections using either the calcium phosphate or the 
DEAE-dextran technique were performed as described (18). 
For transient expression assays, cytoplasmic RNA was 
isolated from HeLa cells 42-48 hr after transfection. SI 
nuclease analysis has been described (19, 20). 
Abbreviations: bp, base pair(s); kbp, kilobase pair(s); MCMV, 
murine cytomegalovirus; HCMV, human cytomegalovirus; SV4O, 
simian virus 40; IE, immediate early. 
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FIG. 1. HindIll restriction map of tbe MCMV genome. Tbe region encoding tbe 2.75-kbp major IE transcript is expanded. Tbe 10.8-kbp 
BamHI fragment (clone pAMB25) and the 2.27-kbp Pst 1 fragment (clone pAMB33) were used together with enhancer trap DNA for 
cotransfection into monkey CV -1 cells. Tbe Xho 1 fragment spanning map units 0.795-0.797 was used to determine the site ofIE RNA initiation 
by S1 nuclease analysis. Tbe direction of transcription of the 2.75-kb IE RNA is indicated by an arrow. 
RESULTS 
A Strong Transcription Enhancer in the MCMV Genome. 
Although viral transcription enhancers usually are associated 
with JE genes (11, 21), we decided to screen the entire 
genome of MCMV, in addition to the region coding for IE 
mRNA, for the presence oftranscription enhancers. Cloned 
enhancerless SV40 DNA (clone pET-I; ref. 18) was cotrans-
fected into monkey kidney CV-l cells with the following 
MCMV-specific DNAs: (I) total MCMV DNA isolated from 
purified virions; (il) DNA from clone pAMB25, spanning map 
units 0.769-0.815 of the MCMV genome and coding for the 
major IE transcript; (im DNA from clone pAMB33, spanning 
map units 0.796-0.806 (Fig. 1) and containing the promoter 
region ofthe major IE transcript. In alt cases, the CV-l cells 
began to lyse 2-3 weeks after transfection, indicating that a 
viable SV40-like virus had been generated. 
Recombinant SV 40-MCMV viral DNAs were isolated and 
cloned in the bacterial plasmid pBR327. Individual recombi-
nant virus clones were reclaimed from the plasmid and tested 
for viability by transfection into monkey CV -1 cells using the 
DEAE-dextran method. Fifteen of 16 clones originating from 
transfection with the entire MCMV genome, 8 of 8 clones 
originating from the pAMB25 transfection, and 6 of 8 clones 
originating from the pAMB33 transfection were viable and 
lysed CV-l cells 12-16 days after transfection. This is about 
the same time it takes to lyse the cells when transfection is 
performed with SV40 wild-type DNA or SV40-HCMV re-
combinant DNA (11). 
By Southem blot hybridization, it was shown that alt the 
analyzed clones hybridized exclusively to the pAMB33 
fragment spanning map units 0.796-0.806 on the MCMV 
genome (data not shown), indicating that there is a strong 
enhancer located in the major JE region. Tbe expectation that 
this enhancer activates transcription from the major IE 
promoter was conftrmed by deletion analysis of the MCMV 
enhancer/promoter region (unpublished data). Additional 
enhancers, ifthey exist in the MCMV genome, must be weak, 
deleted SV40 enhancer seQuence early 
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FIG. 2. Tbe SV40 enbancer trap experiment. (A) HindIll C fragment of wild-type SV40 (nucleotide positions 5171-1046 of the SV40 map; 
see ref. 22). This fragment encompasses the origin ofDNA replication, tbe major initiation site of early RNA, and the enhancer. Tbe 21- to 22-bp 
repeats and tbe 72-bp repeats are sbown by bold arrows. Tbe SV 40 enhancer trap clone pET -1 is an enhancer deletion mutant (nucleotides 99-294 
are deleted) and bas an Xba 1 restriction site inserted· at position 99 (18). (B) HindIll C fragment from the recombinant SV4O-MCMV P1 clone 
containing the MCMV enhancer. It originated from a cotransfection of enbancer trap DNA and the MCMV -specific 2.27-kbp pAMB33 fragment 
into CV -1 cells. Tbe inserted MCMV sequence is 311 bp long. At the Xba 1 site, the Xba 1 linker and four nucleotides of SV40 DNA are deleted; 
at the Kpn 1 site, 11 nucleotides of SV 40 DNA are deleted. (C) HindIII C fragment from the recombinant SV 4O-MCMV B2 clone. It was obtained 
by cotransfection of enhancer trap molecules with the MCMV -specific 10.8-kbp pAMB25 fragment into CV -1 cells. Tbe MCMV insertion is 342 
bp long and is inserted between the Xba I linker and the Kpn 1 site, wbere 14 nucleotides of SV40 DNA are deleted. Tbe sequence overlapping 
in the MCMV enhancer segments present in the two recombinant clones is sbown by black bars. (D) Map of tbe SV 40 genome indicating tbe 
direction of early and late transcription units. 
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because no other sequences from the MCMV genome were 
recovered by the enhancer trap. 
Nucleotide Sequence of the MCMV Enhancer and the 
Flanking JE Region. Two fast-growing MCMV-SV40 recom-
binant clones were chosen for further analysis: B2, derived 
from cotransfection of the 10.8-kbp pAMB25 fragment with 
enhancer trap DNA, and PI, derived from the 2.27-kbp 
pAMB33 transfection. Clone B2 contained a 342-bp MCMV 
fragment ligated to the ends of the enhancer trap, and clone 
PI contained a 311-bp MCMV segment (Fig. 2), overlapping 
with the B2 fragment by 227 bp. In both cases, on either side 
of the enhancer trap 5-15 bp of SV 40 DNA were deleted, 
presumably by exonuclease digestion within the cell prior to 
ligation. No deviation from the wild-type SV 40 sequence was 
found within 300 bp of flanking enhancer trap DNA. 
To accurately determine the location of the enhancer 
within the MCMV genome, the sequence of an 885-bp 
fragment from the major JE region was analyzed (Fig. 3). The 
analysis revealed that the B2 and PI enhancers are both 
colinear with the genomic DNA of MCMV and have not 
suffered any secondary sequence alterations. 
Functional Analysis of the MCMV Enhancer. Classical 
enhancers can stimulate transcription of a heterologous test 
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gene in an orientation-independent way, even when located 
downstream of that gene. To test whether the MCMV 
enhancer satisfies that definition, a HindIII fragment from the 
recombinant MCMV-SV40 clones B2 and PI containing 
MCMV enhancer sequences (ranging from position 5171 to 
1046 on the SV40 map) was cloned in either direction 
downstream of the rabbit ß-globin gene in the plasmid pßG 
(26) (Fig. 4A). Clones containing the enhancer from the SV 40 
wild type and the previously analyzed strong enhancer from 
HCMV were used for comparlson. Transient expression of 
globin messenger RNA in HeLa cells was measured by an SI 
nuclease assay of cytoplasmic RNA, using a ß-globin-specific 
probe. The B2 and PI enhancer segments of MCMV, while 
they are weaker than the enhancer from HCMV, are consid-
erably stronger than the SV40 wild-type enhancer (Fig. 4B). 
When a pßG clone lacking an enhancer was used as a control, 
no transcription ofthe ß-globin gene was detected. Like other 
enhancers (reviewed in refs. 7-9; see also refs. 11 and 18), the 
MCMV enhancer can be inserted in either orientation, yet 
ß-globin gene expression is stimulated to the same extent 
(Fig. 4B). Thus, the MCMV enhancer meets all the criteria of 
a strong transcription enhancer. 
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consensus sequence CCCCATTGACGTCAATGGG 
--MCMV: 
position 
-236 to -218 CaCCATTGACGTCAATGGG 
-537 to -527 AgGTCAATGGG 
-134 to -124 ACGTCAATGGG 
HCMV 18 bp: 
consensus sequence CTAACGGGACTTTCCAA 
MCMV: 
position 
-761 to -744 tCAATAGGGACTTTCCAt 
-668 to -651 tCAATAGGGACTTTCCAt 
-575 to -558 tCAATAGGGACTTTCCAA 
-482 to -465 tCAtTAGGGACTTTCCAA 
-390 to -373 tCAATAGGGACTTTCCAt 
-812 to -804 tCAATAGGG 
-720 to -712 tCAATAGGG 
-627 to -619 tCAATAGGG 
-441 to -433 tCAATAGGG 
-349 to -341 tCAATAGGG 
-297 to -289 tCAATAGGG 
Adenovi rU5: 
consensus sequence AGGAAGTGAAA 
MCMV: 
position 
-125to-116 GGAAGTGAAA 
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~----------------------~I 82 ~----------------------~I P1 
FIG. 3. Structural organization of the MCMV enhancer region. (A) Sequence of the MCMV enhancer and its flanking regions. The 
MCMV -specific enhancer sequence contained in the recombinant SV 4O-MCMV viruses 82 and PI is bracketed_ The cap site is marked by "+ 1. " 
Several cIasses of direct repeats are noteworthy. (I) Two sequences, 181 bp and 180 bp long (solid lines; positions -668 to -487, and -482 to 
- 302), are 92% homologous to each other. (iI) One 13O-bp sequence (solid line; position -827 to -698) is 92% homologous to the 181-bp sequence 
and 95% homologous to the 180-bp sequence. (iil) Five 51-bp repeats (dashed lines); the two far upstream ones are 100% homologous to each 
other; the others are 92% to 98% homologous to the first two. All fIve 51-bp repeats are contained within the 130-, 180-, and 181-bp repeated 
sequences. In addition to the short repeated sequence motifs homologous to HCMV (11) and the sequence GGAAGTGAAA homologous to an 
adenovirus enhancer consensus (21), the TATA box, several CAAT boxes (23), some in opposite orientation, and a CCGCCC motif (24, 25), 
are boxed. (B) Short repeated sequences found in the MCMV enhancer. The short repeats are shown in comparison to the consensus of the 
18-bp and 19-bp repeated sequences of HCMV (11). NucIeotides deviating from the consensus are given by lower case letters. (C) Schematic 
presentation of the MCMV enhancer and its flanking region. The direct sequence repeats are indicated by arrows, and the enhancer segments 
in recombinants 82 and PI are indicated by bars. 
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FIG.4. Functional analysis ofthe MCMV enhancer. (A) To test 
the strength ofthe MCMV enhancer, the HindIll C fragments from 
the recombinants B2 and PI (Fig. 2) containing the MCMV enhancer 
were inserted downstream of the rabbit ß-globin gene in the HindIll 
site of clone pßG (26) in either orientation. Closed circle indicates the 
position of the SV 40 origin of replication. (B) SI nuclease assay. A 
ß-globin gerte clone lacking the first intervening sequence (27) was 
end-labeled at the BamHI site. The single-stranded probe was 
hybridized to 20 J.f,g of cytoplasmic RNA that had been isolated from 
HeLa ceUs transfected with the enhancer-containing pßG clones. 
The hybrids were digested with SI nuclease, denatured, analyzed by 
gel electrophoresis, and autoradiographed. Lanes: 1, pßG-WT3 
containing the HindIll C fragment of SV40 wild-type DNA inserted 
downstream of the rabbit ß-globin gene; 2, pßG-HC~E containing 
the HindIll C fragment from reclosed viral enhancer trap DNA 
lacking the enhancer sequence; 3, pßG-MCMV B2-8; 4, pßG-MCMV 
B2-16; 5, pßG-MCMV PI-8; 6, pßG-MCMV PI-2; 7, HCMV en-
hancer C4 located downstream of the rabbit ß-globin gene (11); 8, 
fuU-length probe (453 nucleotides); 9, pßG-MCMV B2-8, the same 
clone as in lane 3, but a different plasmid preparation was used for 
transfeetion. Tbe sequences protected from SI nuclease digestion are 
354 nucleotides long. Lane M, DNA marker (pBR322 cleaved with 
Hpa 11). 
Initiation Site of the 2.7S·kb M~or IE RNA. To determine 
the position of the MCMV enhancer relative to IE tran scrip-
tion, the initiation site ofthe ml\ior IE RNA was determined. 
SI nuclease analysis was performed by using a single-
stranded end-labeled Xho I fragment spanning the putative 
promoter region (Fig. 1, map units 0.795-0.797) and hybrid-
izing it to RNA isolated from MCMV -infected cells 4 hr after 
infection. After SI nuclease digestion, a single band of 280 
nucleotides was detected (Fig. 5, lane 1). This band was not 
seen when RNA from uninfected mouse 3T6 cells was used 
or when the opposite strand of the Xho I fragment was used 
for hybridization (lanes 2 and 3). These data localize the 
initiation site ofthe major IE RNA (Fig. 3 A and C). The same 
result has been found by an alternative mapping technique, 
where 32P-labeled anti sense cRNA from the IE gene of 
MCMV was hybridized to IE RNA and the hybrids were 
analyzed by gel electrophoresis after digestion with RNases 
A and Tl (unpublished data). Analysis of the sequence 
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FIG. 5. Initiation site of the major JE RNA. Cytoplasmic RNA 
was isolated 4 hr after infection from mouse embryo flbroblasts 
infected with MCMV in the presence of cycloheximide (4). RNA (10 
J.f,g) was hybridized to the end-labeled single-stranded MCMV Xho I 
fragment spanning map units 0.795-0.797 (see Fig. 1). Tbe hybrids 
were digested with SI nuclease, denatured, fractionated by gel 
electrophoresis, and subjected to autoradiography. Lanes: 1, hyc 
bridization of the single-stranded Xho I fragment to IE RNA; 2, the 
same probe hybridized to RNA from uninfected mouse 3T6 ceUs; 3, 
the opposite strand of the end-labeled Xho I fragment hybridized to 
MCMV JE RNA; 4, full-length probe; M, DNA marker (see Fig. 4). 
upstream of the cap site reveals a TAT A box located 26 bp 
upstream of the initiation site determined by SI nuclease 
mapping (Fig. 3). The promoter-proximal end of th~ B2 
enhancer segment is located 101 bp upstream ofthe initiation 
site. This is in agreement with an the other enhancer trap 
experiments where the most proximal promoter components 
of heterologous enhancer/promoters, notably the TATA 
box, seem to be excluded by the enhancer trap (refs. 11, 18, 
28; unpublished data). 
DISCUSSION 
By using the SV40 enhancer trap, we have been able to locate 
a very strong enhancer within the MCMV genome. The en-
hancer sequence incorporated by the recombinant virus is very 
long (342 bp), as are enhancers from other members of the 
herpesvirus group (HCMV, H. saimiri; see refs. 11 and 12). 
Despite the fact that the genome organization of MCMV and 
HCMV is rather different and that no homology has been found 
by standard hybridization techniques (unpublished data), the 
enhancers from the two viruses share some features: the 
MCMV enhancer recovered by the SV 40 enhancertrap is a very 
strong enhancer-apart from the HCMV enhancer, the strong-
est one found to date. In addition, the MCMV enhancer shows 
no obvious cell preference; it can be expressed in a number of 
different cell types-e.g., mouse 3T6 fibroblaSts, human epi-
thelial cells (HeLa) , monkey kidney CV -1 cells, and frog kidney 
B cells (unpublished data). 
A computer analysis of 885 bp of upstream sequence 
containing the enhancer indeed revealed a rather complex 
system of long repeated sequences, mostly located in the far 
upstream enhancer region and upstream of the region recov-
ered by the enhancer trap (Fig. 3). This far upstream region 
also displays strong enhancer activity: in a functional test, a 
fragment of 840 bp (position about -1330 to -488; see Fig. 
3) was found to contain at least as much enhancer activity as 
the MCMV enhancer sequence present in the SV 40-MCMV 
recombinants (position -487 to -147; Fig. 3) (data not 
shown). These expression data and the structure ofthis DNA 
region with several repeats harboring conserved enhancer 
motifs (see below and Fig. 3) indicate that the MCMV 
enhancer is an extremely long enhancer, spanning over 700 
bp. Its full potential is not revealed by enhancer trap 
experiments; because of the packaging constraint of the SV 40 
genome, only sub sets of this long and highly redundant 
sequence can be incorporated. 
Biochemistry: Dorsch-Häsler et al. 
Interestingly, the MCMV enhancer also harbors several 
short sequence motifs that have been identified functionally 
and/or structurally to be important components of other 
enhuncers. The sequence CACCATTGACGTCAATGGG is 
organized as an inverted repeat (palindrome). It is almost 
identical to a 19-bp palindrome present in 5 and 12 copies in 
HCMV (11) and monkey cytomegalovirus (K.-T. Jeang and 
G. Hayward, personal communication), respectively. This 
palindrome, which can be viewed as a homodimer of two 
adjacent sequence motifs, occurs only once in the MCMV 
enhancer. Its right-hand monomer, however, is present 
another two times (Fig. 3B). An additional conserved se-
quence (TCAATAGGGACTITCCAI) exists within the 
MCMV enhancer, which is homologous to an 18-bp sequence 
in the HCMV enhancer. In both enhancers, this sequence is 
present in several copies. Similar to the homodimeric palin-
drome, the 18-bp sequence seems to be composed of two 
adjacent sequence motifs (Fig. 3B), which are, however, not 
identical. Again, one motif (the left-hand half) of this 
heterodimer can be found an additional six times in the 
MCMV enhancer. The other (right-hand) motif constitutes an 
enhancer "core" that has been identified in a variety of 
enhancers (29) and is usually read in the complementary 
strand as the GTGGmG consensus sequence. The MCMV 
enhancer also harbors one copy of the adenovirus enhancer 
consensus sequence (21), one CCGCCC motif (24, 25, 30), 
and several CAA T boxes, often found inverted relative to the 
orientation generally described (23,31). All these motifs have 
been determined to be important components of other 
enhancer/promoter regions (for reviews, see refs. 8 and 9). 
The structure of the MCMV enhancer is compatible with 
our current view of enhancers having a modular structure 
with highly redundant information in which conserved motifs 
of several kinds are separated by less-conserved DNA 
sequences (8, 9). The conserved motifs apparently are bind-
ing sites for specific nuclear proteins. To date the only protein 
that has been characterized is the positively acting tran scrip-
tion factor Spl, which binds to CCGCCC motifs (30). Each 
ofthe larger conserved sequences (the 19-bp palindrome and 
the 18-bp sequence) most likely represents two adjacent 
protein binding sites. Accordingly, we anticipate the palin-
drome to bind two identical factors and the 18-bp sequence 
to bind two nonidentical factors. A similar interpretation for 
binding of two identical factors can, for example, be drawn 
for the inverted repeat sequence regulating the heavy metal 
response ofthe mouse metallothionein I gene (32,33). Thus, 
multiple copies of a variety of sequence motifs apparently 
contribute to the activity of the MCMV enhancer, and it 
seems that information redundancy ("the longer the better") 
is nature's way of obtaining particularly strong enhancers, 
such as the one of MCMV. 
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